Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures

Jun-11

Musculoskeletal Neurology Pharmacoepidemiology

AUTHORS : Prof Sean Hennessy, University of Pennsylvania School of Medicine, 803 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104-6021, United States – Email: hennessy@upenn.edu – Profile: https://www.med.upenn.edu/apps/faculty/index.php/g275/p8396 AND https://www.dbei.med.upenn.edu/bio/sean-hennessy-pharmd-phd

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 20(6):619-25

DOI : 10.1002/pds.2141

Exposure to CYP3A4-inducing and CYP3A4-non-inducing antiepileptic agents and the risk of fractures

More publications

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes